These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 38813084)

  • 21. Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience.
    Simsek C; Esin E; Yalcin S
    J Oncol; 2019; 2019():5483791. PubMed ID: 31015835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer.
    Liu J; He M; Wang Z; Li Q; Xu B
    Oncol Res Treat; 2022; 45(11):681-692. PubMed ID: 35988534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual‑directional effect of vinorelbine combined with cisplatin or fluorouracil on tumor growth and metastasis in metronomic chemotherapy in breast cancer.
    Liu H; Li M; Lin Y; You H; Kou J; Feng W
    Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
    Pietras K; Hanahan D
    J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Outcomes of Head and Neck Cancer Patients Treated with Palliative Oral Metronomic Chemotherapy at a Tertiary Cancer Center in Kerala, India.
    Nv V; Muttath G; Jones J; Shringarpure K; Duraisamy K; Deenathayalan VP; Rathi P
    Gulf J Oncolog; 2020 May; 1(33):68-74. PubMed ID: 32476653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for the use of metronomic chemotherapy in gastrointestinal cancer.
    Filippi R; Lombardi P; Depetris I; Fenocchio E; Quarà V; Chilà G; Aglietta M; Leone F
    Expert Opin Pharmacother; 2018 Sep; 19(13):1451-1463. PubMed ID: 30161003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of nanoparticulate delivery systems in metronomic chemotherapy.
    Yu DH; Ban FQ; Zhao M; Lu Q; Lovell JF; Bai F; Wang C; Guan YY; Luan X; Liu YR; Fang C; Chen HZ
    Biomaterials; 2013 May; 34(16):3925-3937. PubMed ID: 23465835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.
    Cruz-Munoz W; Man S; Kerbel RS
    Clin Cancer Res; 2009 Aug; 15(15):4867-74. PubMed ID: 19622578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells.
    Kareva I
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29027915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide.
    Emmenegger U; Francia G; Chow A; Shaked Y; Kouri A; Man S; Kerbel RS
    Neoplasia; 2011 Jan; 13(1):40-8. PubMed ID: 21245939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mathematical model to study low-dose metronomic scheduling for chemotherapy.
    Arora G; Bairagi N; Chatterjee S
    Math Biosci; 2024 Jun; 372():109186. PubMed ID: 38580078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis.
    Liu Y; Gu F; Liang J; Dai X; Wan C; Hong X; Zhang K; Liu L
    PLoS One; 2017; 12(3):e0173693. PubMed ID: 28296916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of metronomic chemotherapy response using diffusion and dynamic contrast-enhanced MRI.
    Baboli M; Winters KV; Freed M; Zhang J; Kim SG
    PLoS One; 2020; 15(11):e0241916. PubMed ID: 33237905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.
    Lee SJ; Ghosh SC; Han HD; Stone RL; Bottsford-Miller J; Shen DY; Auzenne EJ; Lopez-Araujo A; Lu C; Nishimura M; Pecot CV; Zand B; Thanapprapasr D; Jennings NB; Kang Y; Huang J; Hu W; Klostergaard J; Sood AK
    Clin Cancer Res; 2012 Aug; 18(15):4114-21. PubMed ID: 22693353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling.
    Kweon S; Jeong YS; Chung SW; Lee H; Lee HK; Park SJ; Choi JU; Park J; Chung SJ; Byun Y
    Biomaterials; 2022 Jul; 286():121584. PubMed ID: 35617783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metronomic chemotherapy in ovarian cancer.
    Garg V; Kumar L
    Cancer Lett; 2023 Nov; 579():216469. PubMed ID: 37923056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs.
    Kerbel RS
    Cancer Res Treat; 2007 Dec; 39(4):150-9. PubMed ID: 19746237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metronomic chemotherapy for patients with metastatic breast cancer: Review of effectiveness and potential use during pandemics.
    Fares JE; El Tomb P; Khalil LE; Atwani RW; Moukadem HA; Awada A; El Saghir NS
    Cancer Treat Rev; 2020 Sep; 89():102066. PubMed ID: 32769038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.